Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Post by dacha8881on Apr 14, 2010 10:54am

838 Views

Post# 16989947

why so anemic lately???

RESVERLOGIX
(RVX:Toronto)
Last:
6.96
Volume:
17,180
Quote as of: 14 Apr 2010 10:52 AM ET

Change:
-0.17
Change (%):
-2.38
Bid:
6.93
Ask:
6.96
Bid Size:
8
Ask Size:
14
Day High:
7.13
Day Low:
6.92
# Orders
Shares
Bid
Ask
Shares
# Orders
2
800
6.930
6.960
1400
3
1
900
6.920
6.970
100
1
2
2000
6.900
6.980
500
1
2
1100
6.880
7.000
4000
1
1
200
6.870
7.030
2000
1

Bullboard Posts

FLYHT and WestJet partner on weather forecasting